Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine in acute lymphoblastic leukemia and acute myeloid leukemia
PACTR202301678338690Phase 2Recruiting
- Sponsor
- Armaceutica, Inc.
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pyronaridine in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) (2 arms), sponsored by Armaceutica, Inc. Started Jan 2023; status: recruiting.
02
Drugs
pyronaridine
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on PACTR202301678338690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202301678338690.